Prot #I4V-MC-JAIX: A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Moderate to Severe Atopic Dermatitis (BREEZE-AD6)

Project: Research project

StatusActive
Effective start/end date12/7/186/8/21

Funding

  • Lilly USA, LLC (Prot #I4V-MC-JAIX)